scholarly journals Clinical similarity of the biosimilar ABP 501 compared with adalimumab after single transition: long-term results from a randomized controlled, double-blind, 52-week, phase III trial in patients with moderate-to-severe plaque psoriasis

2017 ◽  
Vol 177 (6) ◽  
pp. 1562-1574 ◽  
Author(s):  
K. Papp ◽  
H. Bachelez ◽  
A. Costanzo ◽  
P. Foley ◽  
M. Gooderham ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document